Salarius Pharmaceuticals (NASDAQ:SLRX – Get Free Report) and Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Profitability This table compares Salarius Pharmaceuticals and […]
Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Chardan Capital in a research note issued on Tuesday, Benzinga reports. They currently have a $30.00 price objective on the stock. Sonnet BioTherapeutics Stock Up 1.9 % Shares of Sonnet BioTherapeutics stock opened at $1.65 on Tuesday. The firm’s […]
PRINCETON, NJ / ACCESSWIRE / May 22, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs, announced
Sonnet BioTherapeutics Announces Review of Strategic Alternatives pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
OPENING CALL Stock futures were little changed on Tuesday with consumer spending in focus, as a slew of earnings from retailers were due. Expected results from Lowe s, Macy s, AutoZone and. -May 21, 2024 at 06:22 am EDT
- MarketScreener